Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Graff

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Journal of Geriatric Oncology|December 21, 2024
Daily life mobility detects frailty, falls, and functioning in older prostate cancer survivors treated with androgen deprivation therapyDeanne C Tibbitts, Martina Mancini, Sydnee Stoyles, et al.
Cancer|May 19, 2016
Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumorsJulie N Graff, Celestia S Higano, Noah M Hahn, et al.
Anti-Cancer Drugs|September 27, 2016
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlatesColin P Bergstrom, Brian Ruffell, Christine M T Ho, et al.
BMC Cancer|March 26, 2026
Protocol for the internet-based lifestyle intervention to eradicate obese frailty in prostate cancer survivors (iLIVE) randomized controlled trial: a type I hybrid effectiveness implementation trialWendy Demark-Wahnefried, Laura Q Rogers, Lisa Zubkoff, et al.
Science (New York, N.Y.)|December 23, 2000
Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigreesN Ertekin-Taner, N Graff-Radford, L H Younkin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 22, 2017
Neoadjuvant Chemotherapy Improves Survival in Patients with Clinical T4b Colon CancerAhmed Dehal, Amanda N Graff-Baker, Brooke Vuong, et al.
Neoplasia (New York, N.Y.)|July 31, 2022
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab)Lauren B Peiffer, James R White, Carli B Jones, et al.
The American Journal of Psychiatry|October 1, 1996
Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implicationsP Pietrini, M L Furey, N Graff-Radford, et al.
Neurology|January 28, 2004
DLB fluctuations: specific features that reliably differentiate DLB from AD and normal agingT J Ferman, G E Smith, B F Boeve, et al.
Journal of the American Geriatrics Society|March 7, 2017
Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation TherapyKerri M Winters-Stone, Esther Moe, Julie N Graff, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Journal of Geriatric Oncology|December 21, 2024
Daily life mobility detects frailty, falls, and functioning in older prostate cancer survivors treated with androgen deprivation therapyDeanne C Tibbitts, Martina Mancini, Sydnee Stoyles, et al.
Cancer|May 19, 2016
Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumorsJulie N Graff, Celestia S Higano, Noah M Hahn, et al.
Anti-Cancer Drugs|September 27, 2016
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlatesColin P Bergstrom, Brian Ruffell, Christine M T Ho, et al.
BMC Cancer|March 26, 2026
Protocol for the internet-based lifestyle intervention to eradicate obese frailty in prostate cancer survivors (iLIVE) randomized controlled trial: a type I hybrid effectiveness implementation trialWendy Demark-Wahnefried, Laura Q Rogers, Lisa Zubkoff, et al.
Science (New York, N.Y.)|December 23, 2000
Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigreesN Ertekin-Taner, N Graff-Radford, L H Younkin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 22, 2017
Neoadjuvant Chemotherapy Improves Survival in Patients with Clinical T4b Colon CancerAhmed Dehal, Amanda N Graff-Baker, Brooke Vuong, et al.
Neoplasia (New York, N.Y.)|July 31, 2022
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab)Lauren B Peiffer, James R White, Carli B Jones, et al.
The American Journal of Psychiatry|October 1, 1996
Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implicationsP Pietrini, M L Furey, N Graff-Radford, et al.
Neurology|January 28, 2004
DLB fluctuations: specific features that reliably differentiate DLB from AD and normal agingT J Ferman, G E Smith, B F Boeve, et al.
Journal of the American Geriatrics Society|March 7, 2017
Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation TherapyKerri M Winters-Stone, Esther Moe, Julie N Graff, et al.
Pageof 12